Results 61 to 70 of about 540,803 (317)

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina   +11 more
wiley   +1 more source

Modular Functional-Metabolic Coupling Alterations of Frontoparietal Network in Schizophrenia Patients

open access: yesFrontiers in Neuroscience, 2019
Background: Brain functional dysconnectivity, as well as altered network organization, have been demonstrated to occur in schizophrenia. Brain networks are increasingly understood to exhibit modular community structures, which provides advantages in ...
Qiong Xiang   +17 more
doaj   +1 more source

Effect of the Eruption of Nishinoshima Volcano in the Summer of 2020 on Air Quality in Fukuoka and Busan

open access: yesAsian Journal of Atmospheric Environment, 2023
A thick foggy weather and worst visibility in Fukuoka, Japan and Busan, South Korea occurred from the late July to early August 2020 due to the Nishinoshima volcanic eruption.
Chang-Jin Ma, Gong-Unn Kang
doaj   +1 more source

Episode 78: In Memoria Karen Dalke

open access: yes, 2018
In this special episode of Knowing Animals we remember Karen Dalke. Karen sadly passed this week. Karen was a passionate animal lover and Animal Studies scholar.
Dalke, Karen, O'Sullivan, Siobhan
core   +1 more source

Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini   +28 more
wiley   +1 more source

Episode 59: Burger with Carol J Adams

open access: yes, 2018
In this episode of Knowing Animals we are lucky to be joined by Carol J. Adams.
Adams, Carol J, O'Sullivan, Siobhan
core   +1 more source

Don’t turn your back on the symptoms of psychosis : a proof-of-principle, quasi-experimental public health trial to reduce the duration of untreated psychosis in Birmingham, UK [PDF]

open access: yes, 2013
Background: Reducing the duration of untreated psychosis (DUP) is an aspiration of international guidelines for first episode psychosis; however, public health initiatives have met with mixed results.
Patterson, Paul   +25 more
core   +1 more source

A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling   +16 more
wiley   +1 more source

Episode 67: Zoopolis with Will Kymlicka

open access: yes, 2018
In this episode of Knowing Animals I am thrilled to be joined by Professor Will Kymlicka from Queens University, Canada. We discuss the book he wrote with Sue Donaldson, ‘Zoopolis: A Political Theory of Animal Rights’.
Kymlicka, Will, O'Sullivan, Siobhan
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy